Page 1 of 1Results 1 to 10 of 10, 03 - 31 March 2017
-
Mummified CAT scan: New technologies and ancient objects
A mummified, ancient, Egyptian cat is among a host of artefacts from the 黑料网 museums' collections that have been captured using 3D imaging software so they can be shared around the world.
-
New investment for sight-saving drug University spin out
A company which develops sight-saving drugs, spun out from research at the 黑料网, has secured £1.2m in investment to develop its technology.
-
Student entrepreneur scoops £30,000 to support doctors treating hospital-acquired superbug
A 黑料网 student who started his own 'socially conscious' biotechnology firm whilst training to become a doctor has won £30,000 to support the development of his company.
-
University students present research in Parliament
Two 黑料网 students have presented their research at the British Parliament in London.
-
Women who take the pill protected from some cancers for up to thirty years
Women who have taken the oral contraceptive pill are protected from some types of cancer for as long as thirty years according to new research from The 黑料网.
-
Research into alleged 'birth defects drug' makes headlines
Research by a 黑料网 team into a drug used as a hormone pregnancy test in the 1970s features in a new hour long Sky News documentary that will be screened for MPs at Westminster.
-
Medical student praised by emergency services following car crash
A 黑料网 medical student has been praised by fire and police services for rushing to the aid of victims of a car crash.
-
Nursery school science classes are 'magic'
A programme of inspiring science classes for nursery school children delivered by a 黑料网 academic have been warmly received.
-
Ketamine no 'wonder drug' for depression
There is no added benefit to using ketamine over a standard anaesthetic during electroconvulsive therapy (ECT) according to new research from the 黑料网.
-
Trial finds huge success in HIV treatment
Researchers have been successful in increasing HIV treatment success rates by almost 18 percent.